Kethandapatti Balaji, MBBS (MD), FRCS, MRCS, LRCP

Treats Adults

Urologist

4.8 /5 398 ratings

(904) 383-1016

Request appointment online

Provider profile Menu

Research at a glance

Top areas of exploration

Prostatic Neoplasms , 15 publications
Prostate , 5 publications
Postoperative Complications , 5 publications
Prostatectomy , 4 publications

Research activity

41 publications

387 citations

Why is this important?

Active clinical trials

A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC who are BCG Na茂ve/Received Incomplete BCG Treatment

Investigator: Kethandapatti Balaji
Status: Accepting Candidates
Ages: 18 Years - 100 Years
Sexes: All

BCG in combination with durvalumab in adult BCG-naive, high-risk NMIBC participants

Investigator: Kethandapatti Balaji
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma

Investigator: Kethandapatti Balaji
Status: Accepting Candidates
Ages: 18 Years - 100 Years
Sexes: All

My publications

41 publications

2025

Investigation of radiomic features on MRI images to identify extraprostatic extension in prostate cancer.

Computer methods and programs in biomedicine

鈥�

2025

Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased 伪-Catenin.

The Prostate

鈥�

2024

MRI-based radiomic features for identifying recurrent prostate cancer after proton radiation therapy.

Journal of applied clinical medical physics

鈥�

2023

Can magnetic resonance imaging differentiate muscle invasion (T2) and lamina propria invasion (T1) urothelial carcinoma of the bladder? A systematic review and meta-analysis of Vesical Imaging-Reporting and Data System accuracy.

Current urology

鈥�